Firozian Farzin, Arabkhani Zahra, Mahboobian Mohammad Mehdi, Mohammadi Mojdeh, Chehardoli Gholamabbas
Department of Pharmaceutics, School of Pharmacy, Hamadan University of Medical Sciences, Hamadan 6517838678, Iran.
Department of Medicinal Chemistry, School of Pharmacy, Medicinal Plants and Natural Products Research Center, Hamadan University of Medical Sciences, Hamadan 6517838678, Iran.
ACS Omega. 2023 Oct 2;8(41):38092-38100. doi: 10.1021/acsomega.3c04187. eCollection 2023 Oct 17.
Indomethacin as a non-steroidal anti-inflammatory drug (NSAID) is commonly used to treat some ocular inflammatory disorders. Unfortunately, indomethacin is a drug that is poorly soluble in water; therefore, it has low efficacy. An attractive approach is the targeted delivery of indomethacin to the cornea using cationic dextran stearate as a polymeric micelle drug carrier. A dextran stearate-glycidyl trimethylammonium chloride (Dex-St-GTMAC) copolymer was prepared through the reaction of GTMAC, stearoyl chloride, and dextran. Then, Dex-St-GTMAC was characterized by Fourier transform infrared (FT-IR) spectroscopy and H NMR spectroscopy. Dex-St-GTMAC forms micelles in the presence of indomethacin. The prepared polymeric micelles were characterized for size, ζ-potential, drug loading, particle morphology, critical micelle concentration, and encapsulation efficiency. To study the irritation potential of the indomethacin-loaded Dex-St-GTMAC, Het-Cam and Draize tests have been performed. Prepared cationic micelles were subjected to the drug release and -corneal permeation test. The dialysis method was used for the preparation of indomethacin-loaded micelles (10, 20, and 30%). Measurement of the particle size showed a mean diameter of 122.1 and 150.9 nm for the drug-loaded micelles. Scanning electron microscopy (SEM) images showed that the morphology of the particles is spherical. 10% formulation was chosen as the best formulation due to more surface charge and reasonable drug loading. ζ-potential measurement for the 10% drug-containing micelles showed a value of +39.1 mV. Drug loading efficiency and the encapsulation efficiency for 10% drug-containing micelles were 6.36 and 63.61%, respectively. The results of the Het-Cam and Draize tests indicated that the indomethacin-loaded Dex-St-GTMAC formulation had no toxicity to eye tissues. Based on our results, the prepared micelles (indomethacin-loaded Dex-St-GTMAC) exhibited a sustained drug release pattern compared to the control group. Indomethacin penetration from the micelles to the excised bovine cornea was 1.75-fold greater than the control (indomethacin 0.1% in phosphate-buffered saline (PBS)). Data from the ζ-potential, SEM, drug loading capacity, and drug release studies indicated that cationic dextran stearate polymeric micelles are an appropriate carrier for the efficient penetration of indomethacin into cornea tissues.
吲哚美辛作为一种非甾体抗炎药(NSAID),常用于治疗某些眼部炎症性疾病。不幸的是,吲哚美辛是一种水溶性很差的药物,因此其疗效较低。一种有吸引力的方法是使用硬脂酸阳离子葡聚糖作为聚合物胶束药物载体,将吲哚美辛靶向递送至角膜。通过将缩水甘油三甲基氯化铵(GTMAC)、硬脂酰氯和葡聚糖反应制备了硬脂酸葡聚糖-缩水甘油三甲基氯化铵(Dex-St-GTMAC)共聚物。然后,通过傅里叶变换红外(FT-IR)光谱和氢核磁共振(H NMR)光谱对Dex-St-GTMAC进行了表征。Dex-St-GTMAC在吲哚美辛存在下形成胶束。对制备的聚合物胶束进行了粒径、ζ电位、载药量、颗粒形态、临界胶束浓度和包封率等表征。为了研究载吲哚美辛的Dex-St-GTMAC的潜在刺激性,进行了鸡胚绒毛尿囊膜(Het-Cam)试验和兔眼刺激试验(Draize试验)。对制备的阳离子胶束进行了药物释放和角膜渗透试验。采用透析法制备了载吲哚美辛的胶束(10%、20%和30%)。粒径测量结果显示,载药胶束的平均直径为122.1和150.9 nm。扫描电子显微镜(SEM)图像显示颗粒形态为球形。由于表面电荷更多且载药量合理,选择10%的制剂作为最佳制剂。对含10%药物的胶束进行ζ电位测量,结果显示为+39. mV。含10%药物的胶束的载药效率和包封率分别为6.36%和63.61%。Het-Cam试验和Draize试验结果表明,载吲哚美辛的Dex-St-GTMAC制剂对眼组织无毒性。基于我们的结果,与对照组相比,制备的胶束(载吲哚美辛的Dex-St-GTMAC)呈现出持续的药物释放模式。吲哚美辛从胶束渗透到切除的牛角膜的量比对照组(0.1%吲哚美辛磷酸盐缓冲盐水(PBS))高1.75倍。ζ电位、SEM、载药量和药物释放研究的数据表明,硬脂酸阳离子葡聚糖聚合物胶束是吲哚美辛有效渗透到角膜组织的合适载体。